Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States
Authors:
- Bryan R. LuceBLBryan R. Luce
- Kristin L. NicholKNKristin L. Nichol
- Robert B. BelsheRBRobert B. Belshe
- Kevin D. FrickKFKevin D. Frick
- Su Xia LiSLSu Xia Li
- Audra BoscoeABAudra Boscoe
- Matthew D. RousculpMRMatthew D. Rousculp
- Parthiv J. MahadeviaPMParthiv J. Mahadevia
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young ChildrenNew England Journal of Medicine, 2007
- Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract InfectionsThe Pediatric Infectious Disease Journal, 2006
- The Underrecognized Burden of Influenza in Young ChildrenNew England Journal of Medicine, 2006
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United StatesJAMA, 2003
- Illness Among Schoolchildren During Influenza SeasonArchives of Pediatrics & Adolescent Medicine, 2002
- The Japanese Experience with Vaccinating Schoolchildren against InfluenzaNew England Journal of Medicine, 2001
- Potential Cost Savings Attributable to Influenza Vaccination of School-aged ChildrenPediatrics, 1999
- The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in ChildrenNew England Journal of Medicine, 1998
- Health Impact of Influenza in the United StatesPharmacoEconomics, 1996
- Patterns of Shedding of Myxoviruses and Paramyxoviruses in ChildrenThe Journal of Infectious Diseases, 1981